Adipo Therapeutic
Mike Clayman currently serves as the Chairman of the Board for Adipo Therapeutics, Nido Biosciences, Ribometrix, and Anokion. Prior experience includes co-founding and leading Flexion Therapeutics as CEO and Director, with additional board member roles at Akebia Therapeutics. His extensive career at Eli Lilly spanned over a decade, where Mike held various leadership positions, including Vice President of Lilly Research Laboratories and Global Regulatory Affairs. Mike Clayman's educational background includes an MD from UC San Diego School of Medicine and a BA in Molecular Biophysics and Biochemistry from Yale University.
This person is not in any teams
This person is not in any offices